Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Gentium

|Includes: Alleghany Corporation (Y)

Gentium, GENT, has a promising drug candidate, Defibrotide, for veno-occlusive disease, graft vs. host disease, and other problems regarding the Liver. There is no current treatment for VODisease. Gentium in Como, Italy. Regards, Joe